Microbiological Testing/Measurement TRIZ Cases

qRT-PCR measurement of HRG mRNA helps identify NSCLC patients likely to benefit from anti-HER3 antibodies and avoid unnecessary treatment.

Sequence-guided nuclease depletion removes ribosomal RNA or genomic DNA from degraded nucleic acid mixtures, improving enrichment before amplification and sequencing.

A fluid medium replaces the air gap during substrate scanning to improve sequencing image resolution, sample density, and reagent efficiency.

Localization tags preserve tissue position while sequencing identifies many unknown proteins, enabling high-throughput spatial protein analysis.

Real-time qPCR quantifies six resistance genes in aquatic products without culture, improving detection completeness for unculturable bacteria.

A microfluidic chip tests multiple reagent conditions on one tissue section to cut sample use and speed assay preparation optimization.

A stratified significance model uses noise and read-frequency distributions to filter false positive cfDNA variants while preserving rare variant detection.

Haploid cell amplification reveals 2+0 SMA silent carriers by separating SMN1 chromosomal arrangement from total copy number.

Spatial barcodes are linked through nucleic acid products to map single-cell positions and correlate analytes with tissue locations.

Combining tumor mutation burden with MHC Class I LOH improves checkpoint inhibitor response prediction and guides cancer treatment selection.

Specific amplification oligomers and probes enable rapid, sensitive multiplex detection of adenovirus, metapneumovirus, and rhinovirus with fewer false positives.

Parallel chemistry and imaging cycles raise nucleic acid sequencing throughput while adaptive quality control helps cut time and cost.

Gene expression changes in CD3+ cells reveal whether low-dose naltrexone is at an effective level, helping tune cancer therapy and limit side effects.

Hybridization-capture replaces SOMAmer eluates with reporter DNA tags, enabling scalable protein quantification by NGS instead of fixed-cost microarrays.

Real-time quality evaluation and adaptive fluidics-imaging control raise sequencing throughput while reducing time and cost.

Methylation-state-specific probes hybridize to converted DNA for in situ readout of regional methylation patterns and disease-linked biomarkers.

Multiplex SNP sequencing quantifies allele frequencies in semen straws to detect contamination near 1% and confirm genetic identity.

Optical trapping and SICS slow nanopore DNA translocation for repeat reads, higher SNR, and precise single-molecule mapping.

Engineered Taq mutants add reverse transcriptase activity, enabling RNA-to-cDNA conversion and PCR amplification without extra enzymes.

3′-end tagging of the non-coding DNA strand enables reusable transcription templates, easier RNA separation, and lower-cost scale-up.

Chemical modification of Lys-C and Lys-N lysine residues suppresses autolysis, reducing LC-MS peptide interference and improving analyte detection.

Unique barcoded capture wells preserve native tissue layout while enabling single-cell spatial detection of analyte levels.

Antibody-DNA conjugates and multiplex PCR quantify AAV capsid and genome titers in one assay, cutting time, cost, and sensitivity limits.

Gene expression profiling classifies asthma subtypes before immunotherapy, improving antibody selection and avoiding unnecessary treatment costs.

Dual capillary electrophoresis quantifies intact AAV genomes and capsid proteins on one platform to distinguish full, partial, and empty capsids.

Synthetic scaffolds capture rejection biomarkers and immune cells early, reducing biopsy need and enabling personalized immunosuppression.

Real-time qPCR with virus-specific primers and probes detects low-level porcine viral RNA in xenotransplant recipients with high specificity.

Combining SKA2 DNA methylation with rs7208505 genotype improves PTSD risk prediction and supports earlier identification of at-risk subjects.

Co-partitioned split oligonucleotide barcodes cut single-cell barcoding cost and material use while preserving reliable cell-of-origin assignment.

Biocatalytic redox assays generate their own electrical signal, enabling selective, sensitive field detection without external power.

DNA-mediated FRET in a double-antibody reagent cuts background fluorescence and improves target protein detection accuracy.

Peripheral blood RNA biomarkers and logistic regression improve objective differentiation of bipolar disorder and schizophrenia.

Visually marked containers and a receptacle holder simplify multiplexed assay setup, guide reagent placement, and reduce processing errors.

Combining IGFBP3 and GGT serum biomarkers improves chronic liver disease assessment accuracy while reducing reliance on invasive biopsy.

A porous polymer structure traps and kills bladder microbes to lower UTI bacterial load without driving antibiotic resistance.

Target-specific primers and tailed random primers capture unknown sequences next to known targets with higher specificity and less off-target sequencing.

Measures MIR302CHG splice-variant RNA by qPCR or ddPCR to detect rare residual pluripotent stem cells without LIN28A cross-reactivity.

Measuring androgen receptor and osteoglycin expression in prostate tissue predicts metastatic hormone-sensitive prostate cancer prognosis without complex microdissection.

High-density spatial barcodes map single-cell analyte location and abundance while reducing protocol burden through modular barcode design.

Multiplex primers and sequencing replace slow culture steps to identify microbial species accurately and profile populations at high throughput.

A hyperthermophile polymerase enables rapid nucleic acid amplification at constant temperature, cutting assay time and equipment needs.

Fluorescent serum N-glycan profiling replaces invasive biopsy and low-sensitivity PSA screening with accurate prostate cancer detection.

Integrated reagent storage and centrifugal fluid routing automate sealed nucleic acid detection while reducing manual handling and cross-contamination.

Quantifying multiple serum or plasma miRNAs improves early pancreatic cancer detection while avoiding invasive biopsy burden.

Barcode-domain probes replace amplification and polymerization steps to enable rapid, low-error nucleic acid sequencing.

Embedded DNA taggants use toehold strand displacement to create fluorescent authentication patterns without bulky lab equipment.

Marker-guided stacking of QTL2.1 and QTL6.1 boosts cucumber fruit number and weight while limiting unwanted wild-trait transfer.

Spatial barcodes added during in situ reverse transcription preserve location and copy number data before amplification bias distorts gene expression reads.

A sulfone solvent and polyvinyl sulfonic acid buffer replaces formamide to speed ISH hybridization with better stability, homogeneity, and handling.

Imprinted gene expression and loss-of-imprinting patterns enable earlier, more accurate tumor diagnosis than morphology-based detection.

PCR amplifies fetal-specific DNA in maternal blood, resolving low-concentration constraints to enable non-invasive prenatal diagnosis.

A multi-component probe system uses enzymatic digestion to release fluorophores from a quenched state.

Small molecule enhancers increase ligation efficiency without interfering with downstream electroporation steps.

Comparing background and post-rotation optical scans detects material in a rotating chamber, preventing false assay results from transfer errors.

A method identifies tumor rejection mediating neoepitopes by plotting mutant and wild-type MHC binding affinities on a bivariate scatter plot.

Replacing clinical assessments with PCR-based Weissella detection improves prediction accuracy and enables early intervention for high-risk pregnancies.

Short peptide sequences block bacterial ribosomal exit tunnels to inhibit protein synthesis, addressing antibiotic resistance without persistent side effects.

Segmented primer design improves detection precision of the RP2-ARHGAP6 fusion gene while managing device complexity.

Dried absorptive matrices preserve extracellular vesicles from finger-prick blood, enabling reliable disease detection without venous sampling.

PCR-based primer sets detect VanA, VanB, and VanC resistance genes in clinical samples, reducing detection time from days to hours.

Assessing FGGY expression via Western blotting and flow cytometry resolves mixed diagnostic results by correlating marker levels with disease severity.

Specific p95 antibodies quantify truncated Her-2 protein levels to resolve detection accuracy and interpretation consistency contradictions.

A mathematical pathway model assigns numeric values to JAK-STAT1/2 cellular signaling activity using target gene expression levels.

Graphene field-effect transistor biosensors detect single nucleotide polymorphisms via electrical conductance changes.

Reconstructing functional interaction networks from splicing perturbation data identifies drug targets despite machinery complexity.

A doped conducting polymer composition captures circulating tumor cells through electrostatic interactions.

Segmented oligonucleotide primers enable efficient reverse transcription and in vitro transcription of full-length cDNA.

A recombinant bacteriophage carries an indicator gene to produce a detectable protein complex upon infecting target bacteria.

Evaluating biomarker profiles against decision rules enables early sepsis detection, bypassing the low sensitivity of conventional culture methods.

Primers incorporate non-natural nucleobase blocks to terminate DNA polymerase extension, preventing unauthorized sequencing of proprietary 5' tails.

A structure-assisted evolution method links random nucleic acid sequences to defined DNA or RNA nanostructures for directed ligand selection.

Analyzes MLH1 V384 alterations to predict primary resistance and progression-free survival, preventing ineffective therapy administration.

Zeta potential forces separate suspended bacteria from settling debris, allowing optical sectioning to quantify concentration without manual microscopy.

Segmented probes detect replication initiation in single cells without compromising multi-molecular versatility.

Specific DNA sequences from Citrullus colocynthis provide monogenic resistance to WmCSV and SLCV without compromising flesh quality.

Segmenting methylation markers in cfDNA improves sensitivity and specificity for colorectal cancer screening.

Segmenting patients by target protein variants enables tailored anti-TOI ligand selection for precise therapeutic intervention.

Gene expression profiling segments tissue analysis to replace invasive procedures, delivering over 90% accuracy for disease classification.

Calculating tunnel current modal values enables direct nucleotide identification and sequencing, eliminating time-consuming fluorescent marker attachment.

Distinct polymer labels on probes create unique conductance signatures, enabling simultaneous differentiation of multiple target oligonucleotides.

A nucleic acid-based linker acts as a force-activated switch to detect molecular interactions through topological changes.

Detecting elevated CD56, CD94, and calcium mobilization identifies dysfunctional NK cells to address therapeutic resistance and extend remission duration.

Automated electrophoretic collection device separates nucleic acid samples using optical detection and controlled dispensing mechanisms.

A capture probe population uses poly(r) sequences and specific binding partners to isolate target nucleic acids.

Modulating waveguide vertical extents adjusts optical confinement to distribute excitation light uniformly across sample wells.

Integrating the reference electrode within the fluid dispenser structure ensures precise droplet alignment for biochemical assays.

Segmenting the molecular barcode with locked nucleic acid sites prevents adapter self-connection, reducing non-specific amplification in lymphoma detection.

Deriving time-ordered feature vectors from nanopore signals to analyze polymer characteristics without resolving individual k-mers.

Computational modeling of the oligosaccharyltransferase catalytic domain enables rational design of optimized oligosaccharide donors and substrate specificity.

RNase H cleaves modified primers at elevated temperatures, eliminating labor-intensive hot-start steps and reducing false positives from primer dimers.

Blood-based nucleic acid probes detect specific miRNAs, resolving the trade-off between high detection accuracy and invasive tissue sampling.

Integrates clinical evaluation with specific single nucleotide polymorphism testing to resolve the trade-off between prediction precision and method complexity.

Ferrocene derivatives with sulfur or phosphorus groups provide high electrochemical potential values, enabling multiplex assays through narrower voltage peaks.

Split luciferase complementation enables direct antibody detection, eliminating multiple incubation steps and reducing equipment complexity.

A genetic analysis system uses cell retention regions on a substrate to capture nucleic acids and introduce unique tag sequences into cleaved fragments.

Segmenting the viral proteome into distinct peptide regions enables differentiation between past infection and vaccination status.

An electrochemical sensor array replaces complex laboratory equipment to detect boar taint compounds rapidly and cost-effectively.

Statistical normalization of chromosome doses detects copy number variations in nucleic acid mixtures, resolving sensitivity limits from sequencing bias.